Ontology highlight
ABSTRACT:
SUBMITTER: Avasarala J
PROVIDER: S-EPMC5605202 | biostudies-literature | 2017 May-Jun
REPOSITORIES: biostudies-literature
Innovations in clinical neuroscience 20170501 5-6
The treatment of multiple sclerosis continues to evolve. However, even with the introduction of B-cell depleting monoclonal antibodies, disability progression continues unabated since B-cell therapies are unable to cross the blood brain barrier and thus are unable to address the disease that lurks within the brain. In this commentary, the author explores the research and practice of using B-cell depleting monoclonal antibody therapies in MS. The author provides discussion on the blood brain barr ...[more]